GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CMG Pharmaceutical Co Ltd (XKRX:058820) » Definitions » Additional Paid-In Capital

CMG Pharmaceutical Co (XKRX:058820) Additional Paid-In Capital : ₩104,641 Mil(As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is CMG Pharmaceutical Co Additional Paid-In Capital?


CMG Pharmaceutical Co's quarterly additional paid-in capital stayed the same from Sep. 2023 (₩104,641 Mil) to Dec. 2023 (₩104,641 Mil) and stayed the same from Dec. 2023 (₩104,641 Mil) to Mar. 2024 (₩104,641 Mil).

CMG Pharmaceutical Co's annual additional paid-in capital declined from Dec. 2021 (₩104,827 Mil) to Dec. 2022 (₩104,641 Mil) but then stayed the same from Dec. 2022 (₩104,641 Mil) to Dec. 2023 (₩104,641 Mil).


CMG Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for CMG Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CMG Pharmaceutical Co Additional Paid-In Capital Chart

CMG Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104,812.22 104,812.22 104,826.57 104,641.44 104,641.44

CMG Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 104,641.44 104,641.44 104,641.44 104,641.44 104,641.44

CMG Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

CMG Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of CMG Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


CMG Pharmaceutical Co (XKRX:058820) Business Description

Traded in Other Exchanges
N/A
Address
Cheongdam-dong 18-20, No. B01, Gangnam-gu, Seoul, KOR, 135-949
CMG Pharmaceutical Co Ltd is the sole pharmaceutical company and an affiliate company of CHA Health Systems. CHA Health Systems are integrated systems which include medical school, pharmacy school, research institutes, general hospitals and many affiliates which are related to stem cell research, biotechnology and pharmaceutical business all over the world.

CMG Pharmaceutical Co (XKRX:058820) Headlines

No Headlines